Total Funding
54
48
Total FundingSeries B raised
Growth Score
-10 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
50448
FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform.
- Deborah Garner: CEOPast Role: FEMSelect, Vice President Business Development
- Boaz Harari: Co-Founder and VP of Research & Development
About the Company
FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes.
The patented delivery system enables the precise guidance, insertion, and
deployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization.
FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel.
